 |
 Video: What is a Stock Split?
|
|
|
| Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems used in the process of manufacturing biological drugs. Co.'s bioprocessing business is comprised of:Filtration, which includes XCell Alternating Tangential Flow systems that are used in upstream perfusion cell culture processing; Chromatography, which includes products used in downstream purification, development, manufacturing and quality control of biological drugs; Process Analytics, which complements and supports its Filtration, Chromatography and Proteins franchises; and Proteins, which are represented by its Protein A affinity ligands and cell culture growth factor products. According to our Repligen stock split history records, Repligen has had 0 splits. | |
|
Repligen (RGEN) has 0 splits in our Repligen stock split history database.
Looking at the Repligen stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Repligen shares, starting with a $10,000 purchase of RGEN, presented on a split-history-adjusted basis factoring in the complete Repligen stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$15.99 |
|
| End price/share: |
$157.06 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
882.24% |
|
| Average Annual Total Return: |
25.68% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$98,262.94 |
|
| Years: |
10.00 |
|
|
|
|
|
